Literature DB >> 19181602

Non-alcoholic steatohepatitis: an overview.

Allison Shifflet1, George Y Wu.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) includes a broad spectrum of fat-induced liver injury, ranging from mild steatosis to cirrhosis and liver failure. The presence of obesity and insulin resistance is strongly associated with non-alcoholic fatty liver and a greater risk of advanced disease. We present here a review of the mechanisms involved in the pathogenesis of NAFLD, advances in the diagnosis, and options for treatment.

Entities:  

Mesh:

Year:  2009        PMID: 19181602     DOI: 10.1016/S0929-6646(09)60026-7

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  8 in total

1.  Treatment options for nonalcoholic fatty liver disease.

Authors:  Brian Lam; Zobair M Younossi
Journal:  Therap Adv Gastroenterol       Date:  2010-03       Impact factor: 4.409

2.  Obesity and metabolic outcomes in a safety-net health system.

Authors:  Michael P Huynh; Patrick T Bradshaw; Michele M Tana; Carly Rachocki; Ma Somsouk
Journal:  Biodemography Soc Biol       Date:  2020 Jul-Sep

3.  Just Drink a Glass of Water? Effects of Bicarbonate-Sulfate-Calcium-Magnesium Water on the Gut-Liver Axis.

Authors:  Antonietta Gerarda Gravina; Mario Romeo; Raffaele Pellegrino; Concetta Tuccillo; Alessandro Federico; Carmelina Loguercio
Journal:  Front Pharmacol       Date:  2022-06-28       Impact factor: 5.988

4.  SIRT1 transcription is decreased in visceral adipose tissue of morbidly obese patients with severe hepatic steatosis.

Authors:  Cíntia dos Santos Costa; Thais Ortiz Hammes; Francieli Rohden; Rogério Margis; Josiane Woutheres Bortolotto; Alexandre Vontobel Padoin; Cláudio Cora Mottin; Regina Maria Guaragna
Journal:  Obes Surg       Date:  2009-12-22       Impact factor: 4.129

5.  Severe diabetes and leptin resistance cause differential hepatic and renal transporter expression in mice.

Authors:  Vijay R More; Xia Wen; Paul E Thomas; Lauren M Aleksunes; Angela L Slitt
Journal:  Comp Hepatol       Date:  2012-04-23

Review 6.  Steatosis and hepatitis C.

Authors:  Jamak Modaresi Esfeh; Kianoush Ansari-Gilani
Journal:  Gastroenterol Rep (Oxf)       Date:  2015-08-13

7.  Association between metabolic syndrome and the development of non-alcoholic fatty liver disease.

Authors:  Yi Wang; Yu Yuan Li; Yu Qiang Nie; Yong Jian Zhou; Chuang Yu Cao; Lin Xu
Journal:  Exp Ther Med       Date:  2013-04-29       Impact factor: 2.447

8.  Improvement of non-alcoholic steatohepatitis by hepatocyte-like cells generated from iPSCs with Oct4/Sox2/Klf4/Parp1.

Authors:  Yueh Chien; Chi-Shuan Huang; Hsin-Chi Lin; Kai-Hsi Lu; Ping-Hsing Tsai; Ying-Hsiu Lai; Kuan-Hsuan Chen; Shou-Dong Lee; Yi-Hsiang Huang; Chien-Ying Wang
Journal:  Oncotarget       Date:  2018-01-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.